From the January/February 2019 issue of HealthCare Business News magazine


MaxQ AI has formed partnerships with GE to incorporate Accipio Ix into its subscription program, and with IBM to add the application to its PACS. The company also has partnerships with Samsung NeuroLogica and EnvoyAl.

“Our goal as a company is to provide intelligent diagnostic decision support tools to the acute care setting,” said Gene Saragnese, chairman and CEO of MaxQ AI. “Many decisions that are made in the ER are time sensitive so we want to make accurate timely decisions. We think these types of tools can help in that type of situation.”


He added that patients are aggressively treated in academic institutions because the physicians have a high degree of expertise, but that is not always the case in community hospitals. MaxQ AI’s aim is to provide these AI-driven applications to physicians so they can have the confidence of an expert.

Accipio Ix received an accelerated pathway through the FDA’s Breakthrough Devices Program. Then, in early November, the company scored 510(k) clearance from the FDA.

Viz.ai is another promising company in the AI for radiology field. In April, its Viz CTP software, which automatically analyzes CT perfusion images, was cleared by the FDA. The technology’s advanced image analysis algorithm automatically generates parametric CT perfusion color maps based on the dynamic effect of the contrast agent through the brain.

The company also has another product called the LVO Stroke Platform that detects and alerts specialists to potential large vessel occlusion (LVO) strokes. It connects to a CT scanner and leverages an AI algorithm to detect the suspected strokes.

Aidoc, an Israel-based start-up is also making big moves in this field. Early last year, it launched the first AI-powered full-body solution for CT analysis.

The Aidoc Full Body Solution is an extension of the company’s head and spine AI solution. This new solution can help radiologists identify medical findings in the head, c-spine, chest, abdomen, etc.

Aidoc has big plans for the future. It is working on AI solutions for MR and is also looking into extending its AI solutions to other major imaging modalities.

When asked what the most exciting aspect of the untapped potential of AI is, Ariella Shoham, vice president of marketing for Aidoc, said, “If I had to say one thing it would be assessing the actual value and showing real influence on patient care. There are so many AI companies that are actually just algorithms that show levels of sensitivity and specificity but are nowhere near an actual implementation in a live setting.”

January/February 2019 Magazine

Read more stories from the January/February 2019 issue

More Magazine Features

Health IT Homepage